Tag: Public Companies

The success of a program. The loss of a client. A grateful conclusion.

The Problem:

Zacks Small Cap Research (SCR) provides in-depth research reports on a diverse range of emerging companies seeking capital, spanning sectors like mining, crypto, biotech, medtech, technology, blockchain, and more. While their analysts produce comprehensive, bank-style reports offering valuable insights into each company’s mission, vision, and market opportunity, their existing marketing strategy presented a challenge. Zacks SCR relied heavily on an outdated email marketing system with a static template, limiting their ability to:

The Opportunity

While this limited approach, coupled with a minimal social media presence, hindered Zacks SCR’s ability to maximize, it provided a unique insight. Because the existing email program, while outdated, still generated consistent traffic, it allowed visibility into a real-time benchmark against which to measure the effectiveness of a new content marketing strategy. In many cases the old program is changed, or discontinued. Continuing the old program might have been seen to cause branding problems. Read on to see how this opened other doors. 

The Content Carnivores Solution:

Content Carnivores was engaged to revitalize Zacks SCR’s marketing efforts and amplify the reach of their research. Recognizing the value of the existing email program as a benchmark, Content Carnivores implemented a multi-faceted strategy that complemented and expanded upon the existing efforts. This included:

Analysis and Results:

The results were compelling: Content Carnivores’ content-driven strategy delivered a 280% increase in website traffic compared to the outdated email marketing approach. This underscored the power of their multi-faceted strategy in attracting and engaging a wider audience. 

By running the existing email program concurrently with the Content Carnivores strategy, Zacks SCR gained the ability to conduct a real-time, head-to-head comparison of the two approaches. This provided invaluable data on the effectiveness of each strategy in driving website traffic and engaging potential investors.

When the CEO decided that the overall program was not impacting the companies covered with regards to increasing their share price, the program was paused. (Note: Content Carnivores programs are targeted to reach investors but never to solicit or encourage stock purchases or to impact the share price. That would be stock promotion. It’s illegal. We’re happy to get fired when the ‘ask’ has even the whiff of that kind of behavior.) 

In effect we have data from before the program, during the program, and then after the program was suspended. These findings emphasized the crucial role of consistent and engaging content marketing in driving website traffic, maintaining online presence, and reaching target audiences.

It’s Just Marketing, right?

The Zacks SCR case study exemplifies the transformative power of a dynamic and comprehensive content marketing strategy in driving investor engagement and amplifying the reach of valuable research. By leveraging content repurposing, multi-platform distribution, and targeted outreach, Content Carnivores enabled Zacks SCR to connect with a wider audience, maximize the impact of their research, and achieve measurable results. In the end, the ability to conduct a real-time comparison of before, after, and after, provides invaluable insights and further validated the effectiveness of the Content Carnivores approach.

In the ever-evolving world of biotech, staying afloat requires more than just groundbreaking science. It demands resilience, adaptability, and a knack for storytelling. This is the story of GeoVax ( $GOVX ), a company that emerged from the crucible of the AIDS crisis, weathered the storms of public opinion, and ultimately found its footing by embracing a consistent and strategic approach to communication.

Early Days and Reinvention: GeoVax emerged from Emory University during the AIDS crisis, armed with a promising technology platform that had the potential to revolutionize vaccine development. Early trials even hinted at a possible cure for AIDS. However, funding for AIDS research was scarce, and the company faced an uphill battle. Going public added to the pressure, and the politicized nature of the AIDS crisis further complicated their efforts. To survive, GeoVax needed to reinvent itself. They shifted focus to their versatile platform, which was based on the science behind the smallpox vaccine. Despite the potential, public interest in vaccines was low, and the anti-vaccination movement presented a significant challenge.

The Social Media Strategy: To navigate this challenging landscape, GeoVax partnered with Content Carnivores to develop a comprehensive communication strategy. They recognized the need to stay in the public eye and connect with retail investors who were uncertain about the company’s future. The strategy centered around creating a series of engaging social media posts and LinkedIn presentations. These posts featured original images that showcased the science behind their platform and highlighted its potential applications. They also leveraged company press releases and actively engaged with affinity groups affected by various diseases.

Riding the Waves of Public Interest: GeoVax cleverly linked their content to disease outbreaks that captured public attention. When the Zika virus threatened pregnancies in South America, they were there to discuss their platform’s potential for developing a vaccine. Similarly, they addressed concerns about Ebola in Sudan and the ongoing fight against malaria. This strategy allowed them to demonstrate the broad applicability of their technology. The turning point came with the COVID-19 pandemic. GeoVax was perfectly positioned to contribute to the global fight against the virus. They actively pursued government grants and continued to refine their technology. While mRNA vaccines took center stage, GeoVax remained persistent, sharing their progress and engaging with investors on social media and LinkedIn.

Building Momentum and Trust: GeoVax’s efforts started to pay off. They secured tens of millions of dollars in funding from investors who had been following their journey. The company successfully uplisted to NASDAQ from the OTC market, fueled by the renewed interest in their work during the COVID-19 pandemic. This move further boosted their credibility and allowed them to generate even more compelling content, showcasing the growing interest and investment in their technology. With increased funding, they advanced their clinical trials, generating proof of concept and expanding to multiple trial sites. This provided a continuous stream of positive news to share with investors and further solidified their position in the biotech industry.

The Payoff: GeoVax’s perseverance ultimately led to a major breakthrough. After countless grant applications and networking efforts, they were awarded a $350 million BARDA grant to pursue next-generation COVID-19 vaccines. Their consistent online presence also allowed them to capitalize on the monkeypox outbreak, raising additional capital as their vaccine showed promise. All of these successes were built on a foundation of consistent communication, strategic opportunism, and a commitment to staying engaged with their audience.

Key Takeaways:

Social Media is a Powerful Tool: Use it to tell your story, connect with investors, and build brand awareness.